MedPath

Antabuse

ANTABUSE®(Disulfiram Tablets USP)IN ALCOHOLISM

Approved
Approval ID

12850de3-c97c-42c1-b8d3-55dc6fd05750

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 18, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Disulfiram

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5034
Application NumberANDA088482
Product Classification
M
Marketing Category
C73584
G
Generic Name
Disulfiram
Product Specifications
Route of AdministrationORAL
Effective DateApril 18, 2012
FDA Product Classification

INGREDIENTS (7)

DISULFIRAMActive
Quantity: 250 mg in 1 1
Code: TR3MLJ1UAI
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Antabuse - FDA Drug Approval Details